comprehensive -WSS

comprehensive

author：fashion 2025-09-30 14:58:05 - browse：8

RHONA WISE/AFP via Getty Images

WASHINGTON — Drugmakers are doing everything to tap the bottomless well of demand for new obesity drugs, and they might get some government help. The agency that regulates Obamacare insurance is considering a technical change that would require insurers to cover obesity drugs in a market of more than 20 million Americans.

Weight loss drugs are a blessing for patients, a boon for drugmakers, and a potentially huge expense for insurers and taxpayers. Insurers have been slow to cover the drugs, called GLP-1 agonists, and without insurance, it costs upward of $16,000 annually for a drug that must be taken indefinitely.

There is a lot of demand for the drugs, but there are barriers to coverage. Medicare by law is prohibited from paying for obesity drugs. State Medicaid programs don’t have to cover them, so most don’t.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： People can get long Covid without testing positive for virus: Study

knowledge

hotspot

WSS

Health officials lay out plans to cope with respiratory virus season

FTC falls short on scrutinizing hospital mergers, study says

BIO: Crackdown on China pharma industry would threaten U.S. drug supply

Trump to be booked at notorious Fulton County Jail at center of DOJ probe

California store owner shot dead in dispute over displaying Pride flag: Police

Cue Health's Covid

knowledge

comprehensive

Wikipedia

After affirmative action ruling, medical educators look to 'holistic review'

Meadows told special counsel he could not recall Trump ever declassifying Mar

Walensky prepares to leave CDC — and Congress — behind

Cell therapy fails to slow type 1 diabetes, but safety is established

Walensky prepares to leave CDC — and Congress — behind

Intellia plays down concerns on accidental germline transmission

Continuity nursing helped my family in our darkest PICU moments

Bird flu outbreak in cows is latest avian flu curveball

Guidelines to prevent youth baseball injuries need more muscle

Why rehabilitation engineers need to center patients in their research

focus

Cholera vaccine supply gets boost as demand surges globally

CDC says it’s too soon to assess risk posed by Covid subvariant

Study: Spinal cord stimulation helps patients with paralysis walk again

CDC says it’s too soon to assess risk posed by Covid subvariant

How the first Native Hawaiian psychiatrist helped diversify medicine

DeSantis wants to import drugs. Biden’s FDA blasted his plan

knowledge

hotspot

hotspot

hotspot